Quest Diagnostics, Inc [DGX] stock prices are up 7.08% to $178.24 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DGX shares have gain 7.10% over the last week, with a monthly amount drifted -0.66%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on April 02, 2025, when Redburn Atlantic initiated its Buy rating and assigned the stock a price target of $195. Previously, Citigroup downgraded its rating to Neutral on March 04, 2025, and kept the price target unchanged to $185. On January 06, 2025, upgrade upgraded it’s rating to Outperform and revised its price target to $174 on the stock. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $172 on December 17, 2024. Robert W. Baird upgraded its rating to Outperform for this stock on October 23, 2024, and upped its price target to $182.
The stock price of Quest Diagnostics, Inc [DGX] has been fluctuating between $137.71 and $182.38 over the past year. Currently, Wall Street analysts expect the stock to reach $186.5 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $178.24 at the most recent close of the market. An investor can expect a potential return of 4.63% based on the average DGX price forecast.
Analyzing the DGX fundamentals
The Quest Diagnostics, Inc [NYSE:DGX] reported sales of 10.52B for trailing twelve months, representing a surge of 15.19%. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.18 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.88.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 172.56 points at the first support level, and at 166.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 181.39, and for the 2nd resistance point, it is at 184.54.
Ratios To Look Out For
It’s worth pointing out that Quest Diagnostics, Inc [NYSE:DGX]’s Current Ratio is 1.09. As well, the Quick Ratio is 0.99, while the Cash Ratio is 0.16. Considering the valuation of this stock, the price to sales ratio is 1.89, the price to book ratio is 2.76 and price to earnings (TTM) ratio is 21.36.
Transactions by insiders
Recent insider trading involved DELANEY MARK E, SVP & Chief Commercial Officer, that happened on May 12 ’25 when 874.0 shares were sold. SVP & Chief Commercial Officer, DELANEY MARK E completed a deal on May 13 ’25 to sell 874.0 shares. Meanwhile, Officer DELANEY MARK E bought 874.0 shares on May 13 ’25.
